Catalog |
name |
Description |
price |
R-R-2364 |
AS2863619 CAS No.2241300-51-4 |
AS2863619/CAS No.2241300-51-4 enables conversion of antigen-specific effector/memory T cells into Foxp3+ regulatory T (Treg) cells for the treatment of various immunological diseases. AS2863619 is a potent, orally active cyclin-dependent kinase 8 (CDK8) and CDK19 inhibitor with IC50s of 0.61 nM and 4.28 nM, respectively. STAT5 activation enhanced by AS2863619 inhibition of CDK8/19, which consequently activates the Foxp3 gene. |
price> |
R-R-2365 |
Corylin CAS No.53947-92-5 |
Corylin/CAS No.53947-92-5 is an orally active flavonoid anti-inflammatory and osteogenic agent that inhibits IL-6-induced STAT3 promoter activity and STAT3 phosphorylation. Corylin also has anticancer, antiatherosclerotic, and ameliorating activity in hyperlipidemia and insulin resistance, inducing adipocyte browning and lipolysis through SIRT1 or β3-AR-dependent pathways. |
price> |
R-R-2366 |
SI-109 CAS No.2429877-30-3 |
SI-109/CAS No.2429877-30-3 is a potent STAT3 SH2 domain inhibitor (Ki=9 nM) with antitumor activity. SI-109 effectively inhibits the transcriptional activity of STAT3 (IC50=3 μM). SI-109 and an analog of CRBN ligand lenalidomide have been used to design PROTAC STAT3 degrader SD-36. |
price> |
R-R-2367 |
SC-43 CAS No.1400989-25-4 |
SC-43/CAS No.1400989-25-4, a Sorafenib derivative, is a potent and orally active SHP-1 (PTPN6) agonist. SC-43 inhibits the phosphorylation of STAT3 and induces cell apoptosis. SC-43 has anti-fibrotic and anticancer effects. |
price> |
R-R-2368 |
Colivelin CAS No.867021-83-8 |
Colivelin/CAS No.867021-83-8 is a brain penetrant neuroprotective peptide and a potent activator of STAT3, suppresses neuronal death by activating STAT3 in vitro. Colivelin exhibits long-term beneficial effects against neurotoxicity, Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease. |
price> |
R-R-2369 |
Fraxinellone CAS No.28808-62-0 |
Fraxinellone/CAS No.28808-62-0 is isolated from the root bark of the Rutaceae plant, Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor and inhibits HIF-1α protein synthesis without affecting HIF-1α protein degradation. Fraxinellone has the potential to be a valuable candidate for cancer treatment by targeting PD-L1. |
price> |
R-R-2370 |
AS1810722 CAS No.909561-15-5 |
AS1810722/CAS No.909561-15-5 is an orally active and potent STAT6 inhibitor with an IC50 of 1.9 nM. AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research. |
price> |
R-R-2371 |
Casticin CAS No.479-91-4 |
Casticin/CAS No.479-91-4 is a methyoxylated flavonol isolated from Vitex rotundifolia, with antimitotic and anti-inflammatory effect. Casticin inhibits the activation of STAT3. |
price> |
R-R-2372 |
HJC0152 CAS No.1420290-99-8 |
HJC0152/CAS No.1420290-99-8 is a signal transducers and activators of transcription 3 (STAT3) inhibitor. |
price> |
R-R-2373 |
L002 CAS No.321695-57-2 |
L002/CAS No.321695-57-2 is a potent, cell permeable, reversible and specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of 1.98 μM. L002 binds the acetyl-CoA pocket and competitively inhibits the FATp300 catalytic domain, blocks histone acetylation and p53 acetylation, and inhibits STAT3 activation. L002 has the potential for hypertension‐induced cardiac hypertrophy and fibrogenesis treatment. |
price> |